Orexo AB (OSTO:ORX) 3-Year Revenue Growth Rate : 1.30% (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Orexo AB 3-Year Revenue Growth Rate?

Orexo AB's Revenue per Share for the three months ended in Dec. 2024 was kr4.65.

During the past 12 months, Orexo AB's average Revenue per Share Growth Rate was -7.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 1.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was -4.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was -0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Orexo AB was 32.20% per year. The lowest was -86.90% per year. And the median was 1.55% per year.

Competitive Comparison of Orexo AB's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Orexo AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orexo AB's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orexo AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Orexo AB's 3-Year Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Orexo AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Orexo AB (OSTO:ORX) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Orexo AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Orexo AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Orexo AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OSTO:ORX) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

0H19:UK C5G:Germany

Address

Virdings alle 32 A, P.O. Box 303, Uppsala, SWE, 75105

Website

https://www.orexo.com

Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline. The majority is from the USA Pharma segment. Geographically, the majority is derived from the United States. USA Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline includes the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.

Orexo AB Headlines

No Headlines